Diagnamed Holdings Corp.

Diagnamed Holdings Corp.

Share · CA25245D1033 (XCNQ)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Diagnamed Holdings Corp.
No Price
Closing Price XCNQ 28.04.2026: 0,07 CAD
28.04.2026 17:43
Current Prices from Diagnamed Holdings Corp.
ExchangeTickerCurrencyLast TradePriceDaily Change
XCNQ: CSE LISTED
CSE LISTED
DMED.CN
CAD
28.04.2026 17:43
0,07 CAD
-0,005 CAD
-6,67 %
Share Float & Liquidity
Free Float 82,82 %
Shares Float 76,12 M
Shares Outstanding 91,92 M
Company Profile for Diagnamed Holdings Corp. Share
Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.

Company Data

Name Diagnamed Holdings Corp.
Company Diagnamed Holdings Corp.
Website https://www.diagnamed.com
Primary Exchange XCNQ CSE LISTED
ISIN CA25245D1033
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO John Karagiannidis
Country Canada
Currency CAD
Employees -
Address 550 Burrard Street, V6C 0A3 Toronto
IPO Date 2022-11-08

Ticker Symbols

Name Symbol
CSE LISTED DMED.CN
Frankfurt D75.F
More Shares
Investors who hold Diagnamed Holdings Corp. also have the following shares in their portfolio:
AUSTRALIA & NEW ZEALAND BANKING GROUP LD CALL 1.855% NTS 28/02/44
AUSTRALIA & NEW ZEALAND BANKING GROUP LD CALL 1.855% NTS 28/02/44 Bond
BSF SUKUK C. 24/29 MTN
BSF SUKUK C. 24/29 MTN Bond